HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Soon-Jung Park Selected Research

Actinin

10/2017Role of α-Actinin 2 in Cytoadherence and Cytotoxicity of Trichomonas vaginalis.
8/2017Trichomonas vaginalis α-Actinin 2 Modulates Host Immune Responses by Inducing Tolerogenic Dendritic Cells via IL-10 Production from Regulatory T Cells.
10/2015Comparison between mixed lysate antigen and α-actinin antigen in ELISA for serodiagnosis of trichomoniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Soon-Jung Park Research Topics

Disease

6Teratoma (Teratoid Tumor)
10/2020 - 09/2011
6Sepsis (Septicemia)
10/2011 - 04/2007
5Ischemia
01/2021 - 09/2011
4Myocardial Infarction
01/2022 - 05/2013
3Wounds and Injuries (Trauma)
01/2019 - 01/2013
3Trichomonas Infections
10/2017 - 10/2015
2Cardiotoxicity
01/2022 - 12/2020
2COVID-19
01/2022 - 12/2020
2Neoplasms (Cancer)
08/2013 - 01/2011
2Septic Shock (Toxic Shock Syndrome)
10/2011 - 09/2007
2Gastroenteritis
09/2011 - 04/2007
2Cysts
01/2009 - 12/2006
1Drug-Related Side Effects and Adverse Reactions
01/2022
1Heart Arrest (Cardiac Arrest)
01/2022
1Bradycardia
01/2022
1Hypotension (Low Blood Pressure)
01/2022
1Muscular Diseases (Myopathy)
01/2022
1Burns
09/2021
1Heart Diseases (Heart Disease)
05/2017
1Phototoxic Dermatitis (Phototoxicity)
12/2015
1Cholera
10/2015
1Lung Neoplasms (Lung Cancer)
08/2013
1Hemolysis
05/2013
1Infarction (Infarctions)
05/2013
1Vascular Diseases (Vascular Disease)
01/2013
1Fibrosis (Cirrhosis)
01/2013
1Wound Infection (Wound Infections)
09/2011
1Carcinogenesis
09/2011
1Atherosclerosis
11/2009
1Inflammation (Inflammations)
09/2009
1Meningoencephalitis
09/2004
1Infections
06/2004

Drug/Important Bio-Agent (IBA)

5Pharmaceutical PreparationsIBA
01/2022 - 08/2013
3matrigelIBA
08/2019 - 09/2011
3ActininIBA
10/2017 - 10/2015
2remdesivirIBA
01/2022 - 12/2020
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2015 - 05/2008
2IronIBA
05/2013 - 04/2007
2CytokinesIBA
10/2011 - 09/2007
1Antiviral Agents (Antivirals)IBA
12/2020
1GoldIBA
08/2019
1CopperIBA
10/2016
1AntigensIBA
10/2015
1Cholera VaccinesFDA Link
10/2015
1dispaseIBA
08/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2013
1Transcription Factors (Transcription Factor)IBA
05/2013
1Hexachlorobenzene (HCB)IBA
01/2013
1erucylphosphocholineIBA
01/2013
1Therapeutic UsesIBA
09/2011
1Type III Secretion SystemsIBA
09/2011
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2009
1NF-kappa B (NF-kB)IBA
09/2009
1Cytoskeletal ProteinsIBA
01/2009
1EnzymesIBA
01/2009
1ProteomeIBA
01/2009
1Proteins (Proteins, Gene)FDA Link
01/2009
1Phosphotransferases (Kinase)IBA
01/2009
1Virulence Factors (Pathogenicity Factors)IBA
11/2008
1DNA (Deoxyribonucleic Acid)IBA
12/2006
1Fibronectins (Fibronectin)IBA
09/2004
1iberin (IMSP)IBA
06/2004

Therapy/Procedure

7Therapeutics
01/2022 - 12/2015
7Transplantation
01/2021 - 01/2011
4Cell- and Tissue-Based Therapy (Cell Therapy)
01/2019 - 12/2015
1Skin Transplantation (Skin Grafting)
09/2021
1Artificial Skin
09/2021
1Ligation
11/2019
1Cell Transplantation
01/2019
1Operative Surgical Procedures
05/2017
1Cardiomyoplasty
05/2013
1Limb Salvage
01/2013